These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 872484)

  • 1. Studies of the anemia of kala-azar in 68 childhood cases. Specific antiparasitic chemotherapy is the most effective treatment.
    Hiçsönmez G; Ozsoylu S
    Clin Pediatr (Phila); 1977 Aug; 16(8):733-6. PubMed ID: 872484
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kala-azar in Afghanistan.
    Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
    J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of Kala azar.
    Singh UK
    Indian Pediatr; 1999 Mar; 36(3):231-6. PubMed ID: 10713835
    [No Abstract]   [Full Text] [Related]  

  • 5. Red cell survival and iron kinetics in kala-azar.
    Musumeci S; Romeo M; D'Agata A
    J Trop Med Hyg; 1974 May; 77(5):106-10. PubMed ID: 4835324
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
    Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
    Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
    [No Abstract]   [Full Text] [Related]  

  • 7. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication.
    Khalil EA; Musa AM; Younis BM; Elfaki ME; Zijlstra EE; Elhassan AM
    Trop Doct; 2011 Jul; 41(3):139-40. PubMed ID: 21676981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
    Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
    J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kala-azar in childhood].
    Ballin A; Theodor R; Boichis H; Rotem Y; Altman G
    Harefuah; 1980 Jun; 98(11-12):501-3. PubMed ID: 7203192
    [No Abstract]   [Full Text] [Related]  

  • 11. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.
    Kumar D; Ramesh V; Verma S; Ramam M; Salotra P
    Ann Trop Med Parasitol; 2009 Dec; 103(8):727-30. PubMed ID: 20030997
    [No Abstract]   [Full Text] [Related]  

  • 13. Imported and autochthonous kala-azar in France.
    Jeannel D; Tuppin P; Brucker G; Danis M; Gentilini M
    BMJ; 1991 Aug; 303(6798):336-8. PubMed ID: 1912774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoconazole in the treatment of visceral leishmaniasis (kala-azar).
    Ahasan HA; Rafiqueuddin AK; Azhar MA; Chowdhury MA
    Trop Doct; 1996 Oct; 26(4):197-8. PubMed ID: 8937249
    [No Abstract]   [Full Text] [Related]  

  • 16. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases.
    Khandpur S; Chaturvedi P; Kumar U; Khaitan BK; Samantaray JC; Sharma VK
    Int J Dermatol; 2010 May; 49(5):565-9. PubMed ID: 20534094
    [No Abstract]   [Full Text] [Related]  

  • 18. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
    Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
    Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kala-azar--an endemic disease close to Switzerland. Apropos of 2 cases in children observed in Geneva].
    Thélin O
    Rev Med Suisse Romande; 1985 Apr; 105(4):363-8. PubMed ID: 2990003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.